drugset / Trial / NCT01270672

Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)

NCT01270672

RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of this study is to determinate the effect of a pre-treatment with carvedilol, a alpha- and beta-adrenergic receptor blocker, on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). The investigators hypothesize that carvedilol will attenuate the cardiovascular and subjective response to MDMA.

Timeline

Start
2011-01
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 50 mg Oral
Subject Midomafetamine Unknown 125 mg Oral